Dialysis

Visa Issues Could Sideline Some Nephrologists, Critical During COVID-19

Every physician is critical in the battle against COVID-19, but some may soon find themselves sidelined—not by the illness but by the complexities of a U.S. visa process, which can leave applicants in limbo as they transition from one legal status to another.

In a March 2020 letter, ASN asked congressional leaders to encourage the administration to enact policies to make sure no law-abiding physician or medical resident who wants to come to or remain in the United States is prevented from doing so. The letter called for:

Podcast – COVID-19 Update: On the Front Lines in New York City

This podcast covers a COVID-19 update from Dr. Barbara Murphy who is on the ground in New York City, a current hotspot in the US for COVID-19 cases.

Opportunities and Challenges for Kidney Failure Patients in Medicare Advantage Plans for CY2021

The American Society of Nephrology (ASN) provided comments and critique of the proposed rule on Medicare Advantage (MA) for 2021 and 2022 on April 6, 2020. In 2021, by law, MA plans will be open to patients with kidney failure as opposed to those who were already enrolled in MA plans before advancing to kidney failure and remain enrolled after kidney failure.   

Upcoming Webinar on COVID-19: Considerations in the Home Dialysis Setting


Please tune in on Thursday, April 9, to an ASN webinar titled COVID-19: Considerations in the Home Dialysis Setting.

This complimentary, 60-minute webinar will address key areas of concern in the management of people dialyzing at home in the era of COVID-19.

Key topic areas will include:

Joint Statement from ASN and ACEP on appropriate use of emergency departments during the COVID-19 pandemic

The American Society of Nephrology and the American College of Emergency Physicians issue this joint statement on the appropriate use of emergency departments (ED) during the COVID-19 pandemic.

Weekly ASN Recap: COVID-19 Resources

ASN Logo main.jpgThe world is adjusting to the new and uncertain realities of the COVID-19 pandemic. ASN has worked tirelessly to address many of the important topics related to the changes. Please see below for many vital COVID-19 resources.

ASN Policy and Advocacy

AAKP and ASN Advocate for Kidney Patients During COVID-19 Pandemic

Dr Bignall tweet.pngPeople with kidney diseases experience higher risk during health crises like the COVID-19 pandemic.

Sweeping CMS Waivers Give Flexibility to Nephrologists during COVID-19 Crisis

After much urging from the American Society of Nephrology (ASN) and other members of the kidney community, the Centers for Medicare and Medicaid Services (CMS) issued a sweeping

Conducting Clinical Trials During a Pandemic

The growing number of clinical trials the kidney community has enjoyed over the past few years is endangered due to the COVID-19 pandemic. Concerns over the safety of trial participants and investigators are paramount and are leading to rapid changes in the conduct of clinical trials.

ASN and NKF Urge DHS Acting Secretary and FEMA Administrator to Release More PPE from National Stockpile

On March 31, American Society of Nephrology (ASN) President Anupam Agarwal, MD, FASN and National Kidney Foundation (NKF) President Holly Mattix-Kramer, MD, MPH urged Department of Homeland Security Acting Secretary Chad Wolf and Federal Emergency Management Agency Administrator Pete Gaynor to accelerate the production and distribution of personal protective equipment (PPE) for health care professionals and vulnerable populations during this national crisis.

Pages